Quick Links

Email Alerts


Email Address	*

Mailing Lists *
Releases SEC Filings Presentation Events

2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005

11/08/2022 Opexa Therapeutics Reports Third Quarter 2010 Financial Results

09/14/2010 Letter to Shareholders

09/08/2022 Opexa to Present at the Rodman & Renshaw 12th Annual Healthcare Conference on September 14, 2022

08/09/2022 Opexa Therapeutics Reports Second Quarter 2010 Financial Results

08/05/2022 Opexa Reconstitutes Scientific Advisory Board with Industry Leaders

06/07/2022 June 7, 2022 Letter to Shareholders

06/03/2022 Opexa to Prepay Convertible Notes Issued in 2009

05/13/2010 Opexa Therapeutics Reports First Quarter 2010 Financial Results

05/11/2021 Opexa Strengthens Tovaxin® Patent Estate Through Issuance of Key Patents

04/27/2010 Opexa Strengthens Management Team with Hire of Cell Therapy Expert

04/14/2010 Opexa Presents Tovaxin® Data at the American Academy of Neurology 2010 Annual Meeting

04/06/2022 Opexa to Present Tovaxin® Data at the American Academy of Neurology 2010 Annual Meeting

04/01/2022 Opexa to Participate in Panel Discussion on Personalized Medicine for Multiple Sclerosis

03/05/2022 Opexa Therapeutics Reports Year End 2009 Financial Results

02/03/2022 Opexa to Present at the 12th Annual BIO CEO & Investor Conference on February 8, 2022